A roadmap to modernize rules so targeted nutrition can reach patients who need it most
Alexandria, VA — The Alliance for Natural Health (ANH) USA today announced the release of a Strategic Roadmap and Action Plan exposing how outdated FDA rules are blocking access to medical foods—science-based nutrition therapies that could help millions of Americans better manage and even reverse chronic disease.
Despite spending more on healthcare than any other country, the U.S. ranks a shocking 80th in global healthy life expectancy and is projected to fall to 108th by 2050. Chronic disease is now the leading driver of healthcare costs, draining families and overwhelming the system.
Increasingly, the science is demonstrating the profound truth of the ancient maxim: “Let food be thy medicine and medicine be thy food.” Yet the FDA has placed medical foods in a highly constricted regulatory framework that makes no sense, leaving patients without access to safe, effective, and affordable nutritional therapies.
“Many nutrients in foods and supplements are essential to the medical management of disease,” said Jonathan Emord, General Counsel for ANH-USA. “Yet FDA rules on medical foods erect anti-competitive barriers that privilege Big Pharma—steering patients toward drugs with significant side effects—while limiting safe, effective clinical nutrition. Those barriers widen the gap between patient need and available care. To achieve the MAHA agenda’s goals of reducing chronic disease and preventable death and disability, we must remove them—and ANH’s Strategic Roadmap and Action Plan shows how.”
Medical foods are specially formulated products designed to meet the unique nutritional needs of a diseased individual—needs that cannot be satisfied by a normal diet alone. Traditionally this has limited medical foods to a few uses for rare diseases, such as low-phenylalanine formulas for patients with phenylketonuria (PKU) or specialized nutrition for individuals with specific chronic illnesses. Unlike supplements or regular foods, medical foods can legally make disease-related claims.
As medical foods are regulated under the Orphan Drug Act, the FDA interprets them as being restricted to rare diseases. As a result, patients with widespread chronic conditions such as diabetes, heart disease, or metabolic syndrome are excluded from accessing these therapies. At the same time, the FDA limits their use to physician supervision, despite most doctors receiving little to no training in nutrition—while qualified nutrition professionals are shut out altogether.
“Medical foods are public health’s best-kept secret,” said J.D. Weir, CEO of Primus Pharmaceuticals, a leading medical foods manufacturer and innovator. “Seventy-five percent of adults have chronic diseases and don’t know these safe, natural prescription products already exist to fight aging and save money. In osteoarthritis alone, medical foods could cut healthcare costs after generic drugs fail by $250 billion.”
ANH-USA’s Strategic Roadmap and Action Plan calls for urgent reforms to free medical foods from regulatory handcuffs and make them more accessible and affordable.
- Modernize the definition. Update the statutory language so medical foods can address common chronic diseases, not just rare ones.
- Expand access and supervision. Allow qualified nutrition professionals—not just doctors—to oversee medical food use.
- Clarify prescription status and enable reimbursement. Give medical foods a clear path to coverage through Medicare, Medicaid, the Veterans Administration, and private insurers.
- Replace regulatory intimidation with guidance. End the warning-letter culture and provide transparent, science-based rules for innovation.
- Educate healthcare professionals. Integrate medical nutrition training into medical, nursing, dietetic, and pharmacy schools nationwide.
“This plan lands at a pivotal moment. Aging Boomers and Gen X’ers face multiple, diet- and lifestyle-driven metabolic deficits—rooted in chronic inflammation, oxidative stress, mitochondrial dysfunction, and immune dysregulation—that are overwhelming health services. Medical foods and targeted nutrition can address these underlying causes, but they must be reimbursable to scale. After years of FDA barriers, the MAHA winds finally create the opening for reform,” said Robert Verkerk, Ph.D., Executive & Scientific Director of ANH.
The Strategic Roadmap and Action Plan paper argues that expanding access to medical foods will not replace conventional medicine, but will give patients the full range of safe, science-backed tools to manage and reverse chronic disease. This shift could help ease the crushing burden of chronic disease on both families and the healthcare system.
The full Strategic Roadmap and Action Plan is available here.